Zhang Jing, Wang Yi, Liu Bo, Liu Xiaoyun, Xu Zhengqin
Department of Gastroenterology, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei 441000, China.
Department of General Surgery, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei 441000, China.
Saudi J Biol Sci. 2022 Jan;29(1):273-278. doi: 10.1016/j.sjbs.2021.08.087. Epub 2021 Sep 1.
Pancreatitis is a fatal disease associated with significant mortality and morbidity. At present, no specific treatment is available for pancreatitis and the patients are mainly treated with supportive medication. The need for specific antipancreatitic chemotherapy is an urgent medical obligation. In the current study, protective effects of the methanolic extract of the berries were investigated in the rat model of acute pancreatitis. Acute pancreatitis (AP) was induced in the male Sprague-Dawley (SD) rats by cerulein injection. Fruit extract of L extract was prepared using the methanol. Treatment effects of were evaluated in AP rats. Serum levels of lipase, amylase, proinflamatory cytokines (TNF-α, IL-6, TL-1β), lipid peroxidase (LPO), myeloperoxidase (MPO) were determined. Histological changes in the pancreas were assessed. treatment prevented the increase in serum amylase and lipase levels, reduced the disease progression in pancreas, and reduced the serum levels of tumour necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β in AP rats. Moreover, significantly suppressed pancreatic edema, inhibited oxidative damage (MPO activity and SOD activity), and inhibited the expression of NF-κB/p65 and activation (phosphorylation) of the inhibitor of NF-κB (IκBα) and p38 MAPKs. Histological examinations showed that significantly reduced the inflammatory and fibrotic changes. The results indicated the potent pancreato-protective effects of in AP.
胰腺炎是一种与高死亡率和高发病率相关的致命疾病。目前,尚无针对胰腺炎的特异性治疗方法,患者主要接受支持性药物治疗。迫切需要开展特异性抗胰腺炎化疗。在本研究中,我们在大鼠急性胰腺炎模型中研究了该浆果甲醇提取物的保护作用。通过注射雨蛙素在雄性斯普拉格-道利(SD)大鼠中诱导急性胰腺炎(AP)。使用甲醇制备该浆果的果实提取物。在AP大鼠中评估其治疗效果。测定血清脂肪酶、淀粉酶、促炎细胞因子(TNF-α、IL-6、TL-1β)、脂质过氧化物酶(LPO)、髓过氧化物酶(MPO)的水平。评估胰腺的组织学变化。该提取物可防止血清淀粉酶和脂肪酶水平升高,减轻胰腺疾病进展,并降低AP大鼠血清肿瘤坏死因子(TNF)-α、白细胞介素(IL)-6和IL-1β的水平。此外,该提取物可显著抑制胰腺水肿,抑制氧化损伤(MPO活性和SOD活性),并抑制NF-κB/p65的表达以及NF-κB抑制剂(IκBα)和p38丝裂原活化蛋白激酶的激活(磷酸化)。组织学检查表明,该提取物可显著减轻炎症和纤维化变化。结果表明该提取物在AP中具有强大的胰腺保护作用。